What Daehan New Pharm does

Daehan New Pharm (KOSDAQ: 317330) is a South Korea-based pharmaceutical company founded in 1984 that operates four business segments: human pharmaceuticals, animal health products, biopharmaceuticals, and the DiNU: health functional food brand. The company employs 397 people (as of December 31, 2024) and is headquartered in the Hyangnam Pharmaceutical Complex in Hwaseong-si, Gyeonggi-do, with an additional industry-academia-research center in Seongnam-si. Its R&D platform spans synthetic small molecules, improved new drugs (superior generics), specialty formulations including DSPT delayed/sustained-release injectables, gastro-retentive (OREST) and orodispersible tablet (ODT) technologies, oral peptide DDS/LNP delivery, multi-target antibody design, AI-based 3D protein-structure drug design, high-throughput ELISA/BLI screening, and next-generation modalities (peptides, recombinant proteins, mRNA/nucleic acid therapeutics, epigenome editing, and companion animal stem cell therapies in clinical trials). The biopharmaceutical pipeline targets cancer, metabolic diseases, immune disorders, dementia, and infectious diseases, with a new GMP-grade injectable manufacturing facility under qualification for early 2027 launch.

Revenue is generated primarily through two streams. The B2B pharmaceutical stream sells human prescription and OTC drugs, plus animal health products, to hospitals, clinics, and physicians via a Medical Representative sales force and to a nationwide network of approximately 22,000 pharmacies. The B2C DiNU: health functional food brand is sold through the company's own online store, Naver Brand Store, and live commerce broadcasts on Naver Shopping Live, Kakao Shopping Live, and CJ Home Shopping 'Donggake', with influencer collaborations (FITVELY, Mona Choi). Exports reach 20+ countries including Vietnam, Pakistan, Cuba, Uzbekistan, and Nigeria, with key products registered with the Uzbek regulator for CIS market entry. Disclosed FY2025 consolidated revenue was approximately KRW 202.4B (~$150M USD), Q1 2026 revenue was KRW 54.8B (+5.8% YoY) with Q1 2026 net profit of KRW 3.0B (+16.3% YoY); operating profit was pressured by elevated COGS and R&D investment for mid-to-long-term growth. The company received a KITA ESG Diagnosis A- rating in 2025 for environmental management practices.

Name

Daehan New Pharm

Legal name

Daehan Nupharm Co., Ltd. (대한뉴팜 주식회사)

Website

https://dhnp.co.kr

Company type

Public

Founded year

1984

Operating status

Operating

Headcount range

51–100 employees

Short description

Daehan New Pharm (KOSDAQ: 317330) is a South Korean pharmaceutical company founded in 1984 operating across human pharmaceuticals, animal health, biopharmaceuticals, and the DiNU health functional food brand, serving hospitals, ~22,000 pharmacies, and consumers via direct sales and live commerce.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Generic & Private-Label Veterinary Pharmaceuticals (HLAMAEAM), Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA), Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Generic pharmaceuticals
• Animal health products
• Biopharmaceuticals
• Health functional foods
• Drug formulation

Headquarters

HQ city

Hwasong

HQ country

South Korea

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Pharmaceutical Products (Human & Animal): Revenue from manufacturing and selling human pharmaceuticals, animal health products, and biopharmaceuticals through prescription channels (hospitals, clinics, physicians) and pharmacy networks. Core B2B revenue stream with both prescription (ETC) and OTC product lines.
2. Health Functional Foods (DiNU: brand): Revenue from health functional food brand DiNU: sold through own e-commerce storefront, live commerce platforms (Naver Shopping Live, Kakao Shopping Live, CJ Home Shopping), pharmacy counters, and online channels. B2C model with direct-to-consumer and retail distribution.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

Daehan New Pharm manufactures and sells pharmaceuticals across three primary categories: human prescription drugs (covering therapeutic areas including antimicrobials, circulatory, respiratory, musculoskeletal, and oncology), animal health products for veterinary use, and biopharmaceuticals developed through AI-integrated drug discovery platforms. The company also markets a separate consumer health functional food brand, DiNU:, distributed through e-commerce, live commerce broadcasts, and retail pharmacies.

Product overview

Daehan New Pharm is a pharmaceutical and healthcare company offering a diversified portfolio across four core business segments: Human Pharmaceuticals, Animal Health Products, Biopharmaceuticals, and Health Functional Foods. The company's products span from traditional pharmaceutical formulations to next-generation biotherapeutics. Its health functional food business operates under the DiNU: sub-brand, focusing on clean-label and premium nutrition products including probiotics, vitamins, melatonin, and specialty supplements. The company also distributes the New Zealand brand Harker Herbals and develops advanced biopharmaceuticals including peptide drugs, recombinant proteins, and stem cell therapies through its dedicated Bio Research Institute.

Differentiator

Problem solved

Functional benefit

Brands

• DiNU (디뉴): Health functional food brand of Daehan New Pharm, offering products such as probiotics (Pharaotics), vitamin C (Ascorbic Acid), MSM, plant-based melatonin, organic curly kale, direct oral probiotics, and children's height-growth product DiNU Key Up.
• DiNU Store (디뉴 스토어)
• Harker Herbals (하커허벌)

Products and services

• Human Pharmaceuticals (인체 의약품) Prescription and over-the-counter drugs for human use, covering antimicrobials, circulatory, respiratory, musculoskeletal, oncology, and central nervous system therapeutic areas. Distributed to hospitals, clinics, and pharmacies through a national medical representative (MR) network.
• Animal Health Products (동물 의약품) Veterinary pharmaceuticals, vaccines, and animal health products for companion animals and livestock, sold to veterinary clinics and farms.
• Biopharmaceuticals (바이오 의약품) High-complexity biopharmaceuticals including peptide drugs, recombinant proteins, multi-target antibodies, stem cell therapies, and epigenome editing therapeutics developed using proprietary AI-integrated platforms.
• Luthione Injection (루치온 주) Human pharmaceutical injection registered for export to the Uzbekistan Ministry of Health, expanding the company's international presence in Central Asia.
• DiNU: Brand Health Functional Foods (디뉴 건강기능식품) Health functional food brand DiNU: offers probiotics, vitamins, and supplements for general consumers. Marketed and sold via the official online store, live commerce broadcasts, and retail pharmacies, with celebrity endorsements and cross-platform promotion.
• DiNU Ascorbic Acid (디뉴 아스코르빈산) Vitamin C (ascorbic acid) supplement under the DiNU: health functional food brand, promoted through live commerce.
• DiNU MSM (디뉴 엠에스엠) MSM (methylsulfonylmethane) joint health supplement under the DiNU: brand, promoted via live commerce.
• DiNU Direct Oral Probiotics (디뉴 다이렉트 구강유산균) Direct oral probiotic supplement under the DiNU: brand targeting general consumer digestive and oral health.
• DiNU Plant-Based Melatonin 5mg (디뉴 식물성 멜라토닌 5mg) Plant-based melatonin 5mg sleep support supplement under the DiNU: brand targeting consumer sleep health.
• DiNU Organic Curly Kale 100 (디뉴 유기농 컬리케일 100) Organic curly kale supplement under the DiNU: brand targeting consumer nutritional supplementation.
• DiNU Key Up (디뉴 키업) Children's height growth functional supplement under the DiNU: brand, also marketed in a Pokémon Edition variant for kids.
• Paraotics (파라오틱스) Probiotic supplement under the DiNU: health functional food brand, promoted through live commerce channels.

Quantifiable outcome

• Children's height growth product DiNU Key Up demonstrated average 0.9 cm height increase after 24 weeks of intake with P-value < 0.0001 statistical significance.
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Four partnerships are on record, tiered minor and core.

• Harker Herbals (하커허벌)minorGTM or Marketing Partner · 18 April 2026Partnership with New Zealand natural health food brand Harker Herbals, which is available in over 1,000 pharmacies and health stores in New Zealand. Daehan New Pharm promotes Harker Herbals products (Manuka Honey Lozenges 90%, Herbal Stick) through CJ Home Shopping LIVE broadcast targeting the Korean market. The brand specializes in natural ingredient-based products with high recognition and trust in the pharmacy natural health food category.
• CJ ENM (CJ 홈쇼핑)coreGTM or Marketing Partner · 18 April 2026Partnership with CJ ENM CJ Home Shopping for live commerce broadcasts promoting Daehan New Pharm's DiNU: health functional food brand and Harker Herbals products. Products featured on CJ Home Shopping's flagship 'Donggake' live commerce program hosted by top show hosts Dong Ji-hyun and Jaysean during prime-time slots. The broadcast was available on CJ Home Shopping TV channel and mobile app.
• Naver Shopping LivecoreGTM or Marketing Partner · 23 October 2025Live commerce broadcast partnership with Naver Shopping Live platform for DiNU: health functional food brand. Regular live shopping broadcasts featuring representative products including Pharaotics (probiotics), DiNU Ascorbic Acid (vitamin C), and DiNU MSM at exclusive discounted prices. Multiple broadcasts conducted in 2025 with various promotional events.
• Kakao (카카오) Shopping LiveminorGTM or Marketing Partner · 15 October 2025Partnership with Kakao Shopping Live platform, expanding live commerce presence beyond Naver Shopping Live to KakaoTalk's shopping tab. First broadcast conducted with YouTuber FITVELY (1.46 million subscribers) in October 2025. Special first-time Kakao Shopping Live discounts offered to viewers.

Scale indicators15 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Kwang Dong Pharmaceutical: Korean mid-cap pharmaceutical company with a comparable diversified portfolio spanning Rx, OTC, supplements, and consumer health brands. Similar business model of selling through Korean pharmacy networks and consumer channels, making it one of the closest structural comparables in scale and product mix.
• Ildong Pharmaceutical: Korean pharma company with a portfolio overlapping Daehan's: prescription drugs, OTC, animal health products, and probiotics/consumer health brands. Comparable diversified mid-cap Korean pharma structure with both B2B prescription and B2C consumer channels.
• Dong-A ST: Korean pharmaceutical company combining branded Rx therapeutics with well-known consumer health brands (e.g., Bacchus, Eubioment). Comparable hybrid prescription-plus-consumer health model with strong Korean domestic distribution, although larger in scale.
• Boryung Pharmaceutical: Korean mid-cap pharmaceutical company operating in branded prescription drugs (notably cardiovascular franchise) with consumer health adjacencies. Similar scale and Korea-domestic focus, with a comparable strategy of pairing prescription drugs with branded health products.

Broad incumbents

• Daewoong Pharmaceutical: Larger Korean pharmaceutical incumbent operating across branded prescription drugs, OTC, and animal health. Comparable four-pillar logic but with materially greater R&D resources and international footprint.
• Hanmi Pharmaceutical: Korean R&D-driven pharmaceutical company with proprietary drug delivery platforms (e.g., sustained-release, controlled-release) and a focus on improved new drugs and biologics. Operates in adjacent technology domains (long-acting injectables, peptides) where Daehan's DSPT/LNP/Orodispersible platforms compete or complement.
• Yuhan Corporation: One of the largest Korean pharmaceutical incumbents with a diversified Rx and consumer health portfolio. Comparable broad-based Korean pharma strategy but with materially larger scale, R&D budget, and international presence.
• GC Biopharma: Korean biopharmaceutical company with plasma-derived products, vaccines, and recombinant biologics. Comparable on the biopharma/biologics manufacturing dimension, particularly relevant as Daehan develops its recombinant protein and cell therapy pipeline.
• Celltrion: Korea's leading biosimilars and biopharmaceutical company. While focused on biosimilars rather than Daehan's diversified portfolio, Celltrion represents the benchmark for Korean biopharma scale and provides context for valuation and competitive positioning in biologics.
• Zoetis: Global leader in animal health pharmaceuticals, vaccines, diagnostics, and now cell therapies (post-VetStem). Provides international benchmark for Daehan's animal health business, particularly its emerging companion animal stem cell therapy initiative currently in outdoor clinical trials.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/daehan-new-pharm-co-ltd

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Daehan New Pharm